Indexed on: 19 Mar '19Published on: 08 Mar '19Published in: Advanced Healthcare Materials
TiO nanoparticles have emerged as satisfactory sonosensitizers in sonodynamic therapy over the years, but shortcomings such as poor drug loading capability and inadequate techniques to construct suitable TiO nanoparticles, limit their broader applications. Hence, in this paper, versatile nanocomposites that combine mesoporous TiO nanoparticles (mTiO s) with the promising photothermal material, polypyrrole (PPY) to exert synergistic therapeutic effects on tumors are fabricated. The PPY-coated mesoporous TiO nanocomposites (mTiO @PPYs) act as drug delivery vehicles and ultrasonically activated sonosensitizers as well as photothermal agents. Besides, mTiO @PPY may have potential as an ultrasound/photoacoustic (US/PA) imaging contrast agent. The mTiO @PPY shows a favorable drug loading and good photothermal conversion ability. Moreover, intracellular reactive oxygen species generation is verified. The in vitro cell experiments on HepG2 and 4T1 cells demonstrate that honokiol (HNK)-loaded mTiO @PPY has satisfactory cytotoxicity under laser and US irradiation, and the results are further validated by animal experiments. The ability of mTiO @PPY as a contrast agent for US and PA imaging is investigated both in vitro and in vivo. The results indicate that mTiO @PPY-HNK has multitherapeutic effects and bimodal imaging property, which shows great prospect as a novel nanosystem in antitumor applications. © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.